IP News

EPO is increasing their fees, but Forresters is not raising theirs

The European Patent Office (EPO) has announced increases of 2-4% to most official fees with effect from 1 April 2022.…

Matthew Holt

Patenting polymorphs: EPO Board of Appeal provides guidance on inventive step (T 325/16)

Whether a new polymorph of a known pharmaceutical compound is considered inventive, and therefore patentable, is a hotly contested question …

The use of post-published data in the assessment of inventive step – referral to the Enlarged Board of Appeal

A recent case before the Board of Appeal (T 0116/18) has highlighted a divergence in law regarding the plausibility requirement …

Brexit and your IP: FAQs

The UK left the European Union on 31 January 2020, and the withdrawal finally took effect, for IP rights, on …

Dr Jack Gunning

Provisional Application Period (PAP) of the UPC has commenced

On Tuesday, 18 January, Austria deposited its instrument of ratification of the Protocol on Provisional Application of the UPC agreement. …

Dr Nick Palmer

What’s New?  The EPO Consults On Novelty Grace Periods

To obtain a valid European patent for an invention, the details must be kept secret before a patent application is …

Kate Selwyn

Changes to PCT sequence listing format delayed until July 2022

Further to our previous article on the new sequence listing standard ST.26 at WIPO, the implementation date of ST.26 has …